Document is current
Any future updates will be listed below
-
Authors
Brummel, Koen
Eerkens, Anneke L. https://orcid.org/0000-0001-8823-196X
de Bruyn, Marco https://orcid.org/0000-0001-9819-9131
Nijman, Hans W. https://orcid.org/0000-0002-1821-3042
- License Information
-
More Information
Article History
Received: 22 September 2022
Revised: 7 December 2022
Accepted: 9 December 2022
First Online: 23 December 2022
Competing interests
: Authors HWN and MdB hold a patent on antibodies targeting CD103 (no 62/704,258).
: Not applicable.
: All authors have approved to publish this manuscript.
